Table 3. Examples of remote phenotypic monitoring devices for potential use in n-of-1 clinical trials. Condition Phenotype Treatments and monitoring ...

The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the clinical trial space. Hybrid or decentralised clinical trials ... (Table 1). These ...

Our final sample consisted of 164 efficacy trials found in 33 NDAs (see Figure 1). The NDAs were supported by a range of 1-13 trials with a median of four trials. See Table S1 for list of NDAs and ...